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ABSTRACT
The Developmental Origins of Health and Disease (DOHaD) theory predicts that prenatal and early life 
events shape adult health outcomes. Birth weight is a useful indicator of the foetal experience and has 
been associated with multiple adult health outcomes. DNA methylation (DNAm) is one plausible 
mechanism behind the relationship of birth weight to adult health. Through data linkage between 
Generation Scotland and historic Scottish birth cohorts, and birth records held through the NHS 
Information and Statistics Division, a sample of 1,757 individuals with available birth weight and DNAm 
data was derived. Epigenome-wide association studies (EWAS) were performed in two independently 
generated DNAm subgroups (nSet1 = 1,395, nSet2 = 362), relating adult DNAm from whole blood to birth 
weight. Meta-analysis yielded one genome-wide significant CpG site (p = 5.97x10−9), cg00966482. There 
was minimal evidence for attenuation of the effect sizes for the lead loci upon adjustment for numerous 
potential confounder variables (body mass index, educational attainment, and socioeconomic status). 
Associations between birth weight and epigenetic measures of biological age were also assessed. 
Associations between lower birth weight and higher Grim Age acceleration (p(FDR) = 3.6x10
−3) and shorter 
DNAm-derived telomere length (p(FDR) = 1.7x10
−3) are described, although results for three other 
epigenetic clocks were null. Our results provide support for an association between birth weight and 
DNAm both locally at one CpG site, and globally via biological ageing estimates.
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Introduction
The Developmental Origins of Health and Disease 
theory (DOHaD) states that through developmental 
plasticity, the foetal experience can permanently influ-
ence adult health [1]. The theory’s main proponent, 
David Barker, originally relied on birth weight as an 
CONTACT Riccardo E. Marioni riccardo.marioni@ed.ac.uk Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular 
Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK 
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Research in Context 
Evidence before this study 
The associations between birth weight and various adult health outcomes have been well established. DNA methylation (DNAm) is a plausible mechanism through 
which early life experiences may continue to affect health throughout the lifecourse; however, evidence for birth weight associations with DNAm in adulthood has not 
yet been robustly established. This is likely due to small sample sizes of previous studies, as well as the use of poor-quality birth weight data, such as binary ‘low/normal’ 
variables or retrospective self-report. Alternatively, work has attempted to describe the persistence into adulthood of DNAm at sites identified at birth. 
Added value of this study 
We investigated genome-wide associations between DNA methylation patterns from whole blood in adulthood and data linkage-derived, continuous birth 
weight data, in a meta-analysis of two DNAm subsets of data from the same parent cohort (nSet1=1, 395; nSet2=362). We identified one epigenome-wide 
significant CpG site which is, to our knowledge, the first significant EWAS result reported for birth weight in an adult sample. In addition, we demonstrate 
accelerated biological ageing in lower birth weight individuals, using two DNAm-derived measures of biological ageing; GrimAge – an epigenetic clock trained 
on mortality data - and a DNAm derived measure of telomere length. Together, these results suggest differential methylation exists in adulthood related to 
birth weight, and this may be relevant to health and mortality. 
Implications of all the available evidence 
Although CpG sites differentially methylated with birth weight at parturition may not remain so throughout life, the adult epigenome may still 
provide information on the relationship between birth weight and health outcomes. The adult epigenome, therefore, may represent a useful 
archive of the foetal experience which results in birth weight variability, and this may provide clinically useful information in mid-life. 
Supplemental data for this article can be accessed here.
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index of foetal nutrition – an assumption that has 
been contested by the awareness that multiple factors 
can influence birth weight [2]. Maternal stress, illness, 
and socioeconomic status [3–5] are among modifiable 
influences over offspring birth weight. In addition, 
foetal genetics and maternal genetics both influence 
birthweight, the latter acting through the intrauterine 
environment [6,7]. Thus, birth weight can be seen as 
an index of the general foetal experience.
There is strong, well-replicated evidence for an 
association between birth weight and adult health. 
There is particularly consistent evidence for asso-
ciations between low birth weight and poor cardi-
ovascular outcomes, such as heart disease, type II 
diabetes, stroke, and hypertension [8–11], as well 
as poorer cognitive ability and a raised risk for 
mood disorders [12,13]. Birth weight is clinically 
conceptualized as ‘low’ below 2.5 kg [14], however 
it can also be analysed on a continuous scale. 
These associations are found after accounting for 
adult lifestyle factors, such as smoking and body 
mass index (BMI), indicating a residual association 
between birth weight and adult health outcomes.
Prenatal factors affect the foetus in its highly 
plastic state, giving rise to birth weight variability, 
and also to developmental changes which perma-
nently affect the function and health of organs and 
systems [1]. Given the genetic and environmental 
contributions to birth weight variability, epigenetic 
modifications such as DNA methylation (DNAm) 
might provide insights into the pathways and 
mechanisms through which these associations 
with health become manifest. DNAm is typically 
characterized by the addition of a methyl group to 
cytosine nucleotides in the context of cytosine- 
guanine (CpG) dinucleotides. DNAm changes are 
linked to the regulation of gene expression, pro-
viding a possible mechanism through which envir-
onmental influences may have lasting biological 
effects [15]. Therefore, DNAm is one putative 
mechanism through which developmental experi-
ence may relate to adult health.
Birth weight associations with DNAm have 
been previously described in neonatal blood [16– 
18] and during childhood [19], seeming to dimin-
ish into adolescence and beyond [16,18]. The 
established association between differential 
DNAm and birth weight in these highly plastic 
early years raises the possibility of a direct effect 
of transcriptional up- or down-regulation on the 
development of organs and tissues [20]. This is 
one way in which DNAm may mediate the asso-
ciation between birth weight and adult health. It is 
possible, however, that examining only differential 
DNAm patterns which persist from birth into the 
later years ignores the full adult epigenome which, 
despite having changed since birth, may provide 
information on a relationship between birth 
weight and downstream health outcomes never-
theless. Many of the health phenotypes associated 
with birthweight present in adulthood, so the 
question remains whether we can see biological 
marks of these associations laid down in the 
methylome. It has, for instance, been demon-
strated that prenatal famine exposure is associated 
with differential methylation in late adulthood 
[21]. It is therefore plausible that other prenatal 
factors may continue to influence DNAm into 
adulthood. While none of the longitudinal 
DNAm analysis studies have yet identified any 
epigenome-wide significant evidence of persistent 
CpG methylation in adulthood, there are some 
associations which do have p < 1x10−5 [18] but 
do not withstand Bonferroni correction for multi-
ple testing. This may be tentatively interpreted as 
evidence that the adult epigenome holds informa-
tion relating to birth weight, so a full, unbiased 
scan of the adult methylome seems a logical step. 
We would hope for this agnostic approach to 
confirm any genuine DNAm relationships in loci 
identified in other samples at birth, as well as 
revealing any new sites which might provide infor-
mation on biological pathways through which the 
birth weight/health relationship is operating.
In addition to the stand-alone importance of 
discovering DNAm associations with birth weight 
in adults, recent work has revealed the utility of so- 
called ‘epigenetic clocks’ in demonstrating elements 
of vulnerability to disease and mortality [22]. These 
clocks attempt to calculate an individual’s biological 
age, and the residual of biological age regressed on 
chronological age (i.e. age acceleration) can be used 
to indicate health vulnerabilities. The earliest ver-
sions of epigenetic clocks, such as the pan-tissue 
Horvath clock [23] and the leukocyte-based 
Hannum clock [24], were trained simply on chron-
ological age. The second generation of these clocks 
added clinical information on top of chronological 
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age, to improve the biological relevance of the mea-
sure. The PhenoAge clock is of this second genera-
tion, it is based on clinical biomarkers known to 
associate with mortality [25], as is GrimAge (a 
predictor combining DNAm proxies for smoking 
and seven plasma proteins and trained on time-to- 
death [26]). Finally, a DNAm-derived estimate of 
telomere length outperforms phenotypic measures 
of telomere length [27], with validated utility in 
predicting lifespan and other aspects of health 
[27,28]. DNAm associations with birthweight, 
together with epigenetic clock analyses, have the 
potential to describe the known associations 
between birthweight and many aspects of whole- 
body health in adulthood.
Here, we report an Epigenome-Wide 
Association Study (EWAS) of birthweight using 
whole blood DNA derived in an adult sample, 
and associations between birth weight and five 
epigenetic clocks. While previous work has 
attempted to find persistent DNAm relationships 
to birth weight from infancy to adulthood [16,18], 
none have performed an agnostic, genome- 
wide study of DNAm in adults. We, therefore, 
hypothesize that while birth weight associated 
DNAm patterns may change over time, differences 
will exist in adulthood.
Materials and methods
This study was performed on a subgroup of the 
Generation Scotland (GS) cohort whose birth-
weight data were collected at parturition in histor-
ical cohort studies. Data linkage strategies were 
employed to ascertain birthweight in grams from 
those historical cohorts. A subgroup of these indi-
viduals for whom DNA methylation data were 
processed formed the sample for EWAS and epi-
genetic clock analyses (Figure 1).
Generation Scotland and other cohorts
Generation Scotland (GS) is a Scottish family-based 
cohort n = 23,690 [29]. Data were collected from 
participants between 2006 and 2011. GS is a deeply- 
phenotyped cohort, allowing examination of many 
aspects of adult health, alongside genomic and bio-
metric measures. In addition, 98% of GS participants 
gave informed consent for data linkage to routinely 
collected health data and to information from other 
Scottish population cohort studies, both current and 
historical. These include several with neonatal and 
maternity information: the Aberdeen Children of the 
1950s [30]; the Aberdeen Maternity and Neonatal 
Databank [31]; the Walker Birth Cohort [32]; and 
the Scottish Morbidity Records ([33], SMR02 – the 
Maternity Inpatient and Day Case record, and 
SMR11 – the Neonatal Inpatient dataset). Birth 
weight in grams, alongside gestational age at birth 
and twin information, was collated from these 
sources and linked to adult GS records for 4,710 
participants (Supplementary File 1, Figure 1). Birth 
weight data derived from health records taken at 
birth has been shown to improve slightly on self- 
reported birth weight, which is often used in popula-
tion cohorts [34].
Statistical analyses
All analyses were conducted in R version 
3.5.1 [35].
To control for the known effects of gestational 
age and sex on birthweight [36], we considered the 
scaled residuals (mean=0, SD=1) from a regression 
model in place of raw birth weight throughout:
Birth weight gð Þ esexþ gestational age 
These are referred to as ‘birth weight residuals’ 
hereafter.
Epigenome-wide association study
Peripheral whole blood genome-wide DNA methy-
lation was profiled in Generation Scotland in two 
different sets of ~5,000 samples. First, data were 
generated for 5,190 individuals, using the Illumina 
HumanMethylationEPIC BeadChip (Illumina Inc., 
San Diego, CA). Quality control and normalization 
were carried out as described elsewhere ([37,38]; 
Supplementary File 2). Birth weight and gestational 
age information were available for n = 1,395 of this 
methylation set (Figure 1), which will hereafter be 
referred to as ‘set 1’.
The second set of DNAm data used a near iden-
tical protocol (Supplementary File 2), creating an 
independent set of methylation data for an addi-
tional 4,450 GS participants. In this replication sam-
ple, a further 362 participants with both birth weight 
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and gestational age information were used, hereafter 
called 'set 2'.
The birth weight residuals described above were 
used in the EWAS model, which was run using the 
‘limma’ package in R (empirical Bayes moderated 
t-statistics). The set 1 EWAS model used CpGs 
corrected for relatedness (Supplementary File 2), 
as the first batch of DNAm data were collected on 
related individuals:
CpG ~ birth weight residuals + age + sex + 
smoking [ever/never] + smoking pack years + 20 
methylation PCs
The 20 methylation PCs were included to try and 
eliminate unmeasured confounders in the DNAm 
data. Additional covariates (estimated white blood 
cell proportions – CD4T, CD8T, Granulocytes, 
BCells, Natural Killer cells – and methylation 
batch), which were regressed out during the related-
ness pre-correction for the set 1 dataset, were also 
included in the set 2 dataset of unrelated individuals.
EWAS findings are considered epigenome-wide 
significant if p < 3.6x10−8 [39].
Meta-analysis of set 1 and set 2 samples
An inverse variance-weighted meta-analysis of the 
set 1 and set 2 EWASs was performed using the 
METAL software package. Summary statistics from 
the set 1, set 2, and meta-analysis EWASs are avail-
able at https://doi.org/10.7488/ds/2876.
Subsample analysis excluding preterm births
To account for the possible differences between pre-
term- and term-born infants, we re-ran the analyses 
detailed above on a subsample excluding those with 
gestational age <37 weeks. This is in line with the 
World Health Organization’s guidelines on preterm 
birth which states that birth before 37 completed 
weeks of gestation should be defined as preterm [40]. 
The total subsample had nSet1 = 1,346, nSet2 = 351, 
resulting in a total nMeta = 1,697. By contrast, the full 
sample discussed in this report comprises both pre-
term and term born individuals.
Sensitivity analysis
As a sensitivity analysis, the EWAS meta-analysis 
was re-examined, fitting additional covariates 
individually, and together in a fully-adjusted model. 
Covariates were selected to account for additional 
lifestyle factors which may associate with DNAm or 
birth weight. These variables could represent con-
founding or mediating factors on the relationship 
between birthweight and adult DNAm. One of 
these covariates was socioeconomic status as ranked 
by the postcode-derived Scottish Index of Multiple 
Deprivation (SIMD). Socioeconomic status is posi-
tively associated with birth weight [41], and has been 
associated with DNAm variability [42]. BMI was 
included as a covariate in the sensitivity analyses, as 
is has been shown to associate with birth weight [43], 
and with DNAm [44]. The number of years of edu-
cation was also included as educational attainment 
associates with DNAm in adulthood (most likely via 
its links to smoking) [45,46], and birth weight has 
been associated with educational attainment [47]. 
For detail on acquisition of covariate data see 
Supplementary File 1. Correction for smoking and 
20PCs were already included in the EWAS model. 
Set 1 DNAm data were pre-corrected for batch, cell 
counts, and relatedness. The fully-adjusted 
model was:
CpG ebirth weight residualsþ ageþ sexþ BMI þ SIMDþ years of education
þ smoking ever=never½ � þ smoking pack yearsþ 20 methylation
PCsþ batch set 2 only½ � þ cell counts set2 only½ �
Epigenetic clock analyses
Detail on the estimation of the five epigenetic clocks 
used have previously been reported elsewhere [22]. 
Briefly, penalized regression models were used to 
identify subsets of CpG sites that predict chronologi-
cal age [23,24], ’phenotypic age’ [25], telomere length 
[27], and survival [26]. The clocks either trained pre-
dictors directly on the outcome (e.g., chronological 
age or telomere length), or via surrogate markers (e.g., 
protein levels and biomarkers that are known to asso-
ciated with biological/health processes). The Horvath 
clock uses DNAm from 51 tissues and cell types to 
yield a pan-tissue predictor of chronological age [23]; 
the Hannum clock also predicts chronological age, 
but using blood-based DNAm [24]. The more 
recently developed PhenoAge incorporates blood- 
based DNAm proxies for clinical biomarkers found 
to associate with mortality risk, inflammatory and 
blood-based markers, as well as chronological age, in 
a ‘phenotypic age’ predictor that associates with 
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healthspan and lifespan [25]. GrimAge takes a similar 
approach, using blood-based DNAm estimates of 
seven plasma proteins, as well as smoking pack years 
and chronological age to predict time to death [26]. 
Finally, DNAmTL is a blood-based DNAm estimator 
of telomere length (a measure of cellular ageing), 
found to outperform measured telomere length in 
prediction of mortality [27]. The residuals from 
regressions of these predictors on chronological age 
gives an index of biological age acceleration. Here, we 
used linear regression to examine the association 
between birth weight (outcome) and the five sets of 
age acceleration residuals, with covariate adjustment 
for age, sex, methylation ‘set’, and estimated white cell 
proportions. Correction for multiple testing was car-
ried out using false discovery rate p < 0.05 for epige-
netic clock analyses.
Ethics approval and consent to participate
All components of GS received ethical approval 
from the NHS Tayside Committee on Medical 
Research Ethics (REC Reference Number: 05/ 
S1401/89). GS has also been granted Research 
Tissue Bank status by the Tayside Committee on 
Medical Research Ethics (REC Reference Number: 
10/S1402/20), providing generic ethical approval 
for a wide range of uses within medical research.
Results
Population characteristics
There were 1,757 Generation Scotland (GS) partici-
pants with both birth weight and DNAm informa-
tion available (Table 1). The set 1 population was 
59.2% female, with a mean birth weight of 3,377 g 
(SD = 518 g), and gestational age of 40 weeks 
(SD = 1.8). The set 2 population was 55.8% female, 
with a mean birth weight of 3,421 g (SD = 535.4 g), 
and mean gestational age of 39.7 weeks (SD = 1.5). 
The minimum birth weight in the sample was 907 g, 
the maximum was 5,090 g. Using the clinical cut-off 
of 2,500 g, 4.8% (n = 84) of the sample were of 
clinically ‘low’ birth weight [14]. This means the 
data describe DNAm relationships to birth weight 
across the full spectrum.
Epigenome-wide association study of birthweight
The set 1 EWAS of birth weight revealed no CpGs 
significant at the genome-wide level (p < 3.6x10−8 
[39];), although 19 CpGs had P < 1x10−5 (minimum 
p-value of 6.05 × 10−8 for cg00966482) (Figure 2(a); 
Supplementary Table 1). The 19 CpGs were largely 
uncorrelated, with the exception of three CpGs 
(located within CASZ1 – two within 200 base pairs 
of each other, with the third site around 11kb away – 
Supplementary Table 1) that had absolute r ≥ 0.6.
Table 1. Population characteristics of the Set 1 and Set 2 EWAS samples.
Phenotype Sample EWAS Sample Replication Sample
N Mean SD N Mean SD N Mean SD
Age (years) 4, 710 29.5 10.9 1, 395 37.1 14.7 362 25.8 5.2
Birthweight (g) 4, 710 3, 399 516 1, 395 3, 377 518 362 3, 421 535.4
Gestation (weeks) 4, 710 39.8 1.7 1, 395 40 1.8 362 39.7 1.5
BMI (kg/m2) 4, 385 25.2 5.2 1, 387 26.1 5.4 360 24.9 4.8
Education* 4, 411 5 4–6 1, 317 5 4–6 350 5 4–6
N % N % N %
Sex – Male 2, 025 43 569 40.8 160 44.2
Female 2, 688 57 826 59.2 202 55.8
Socieconomic Status** (4, 389) (1, 310) (337)
Quintile 1 (most deprived) 621 14.2 207 15.8 65 19.3
Quintile 2 717 16.3 210 16 57 16.9
Quintile 3 715 16.3 183 14 62 18.4
Quintile 4 1, 064 24.2 301 23 72 21.4
Quintile 5 (least deprived) 1, 272 29 409 31.2 81 24
Smoking (4, 525) (1, 344) (357)
Current Smoker 918 20.3 257 19.1 88 24.6
Ex-Smoker (<12 months) 237 5.2 56 4.2 26 7.3
Ex-Smoker (>12 months) 662 14.6 273 20.3 48 13.4
Never Smoker 2, 708 59.8 758 56.4 195 54.6
* Median and Interquartile range reported. Education was coded as an ordinal variable: 0 = 0 yrs, 1 = 1–4 yrs, 2 = 5–9 yrs, 3 = 10–11 yrs, 
4 = 12–13 yrs, 5 = 14–15 yrs, 6 = 16–17 yrs, 7 = 18–19 yrs, 8 = 20–21 yrs, 9 = 22–23 yrs, 10 = ≥24 yrs. 
**SIMD Quintile. SIMD is the Scottish Index of Multiple Deprivation, a postcode-derived index of socioeconomic status. The quintiles derived on the 
full Generation Scotland cohort ranged from 1 (most deprived) to 5 (least deprived). 
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There were no genome-wide significant associa-
tions in the set 2 sample (n = 362) (Figure 2(b); 
Supplementary Table 2). Of the 19 CpGs that 
exceeded p < 1x10−5 significance threshold in the set 
1 EWAS, two reached nominal significance (p < 0.05) 
in the set 2 analysis: cg00590817 (p = 0.0069), and 
cg00966482 (p = 0.031). The latter CpG was the most 
significantly associated site from the set 1 EWAS. 
There was moderate concordance between the effect 
sizes of the top 19 DNAm associations with birth-
weight in set 1, and the same CpGs in the set 2 analysis 
(r = 0.59) (Figure 3).
Meta-analysis EWAS
Meta-analysis of the set 1 and set 2 EWAS samples 
resulted in a genome-wide significant association 
between birthweight and DNAm at the CpG site 
cg00966482 mapping to the HERV-FRD and 
LOC221710/SMIM13 genes (β = 0.0206, SE = 
0.0035, p = 5.97x10−9; Figure 2(c); Supplementary 
Table 3). There were 36 CpG sites with p < 1x10−5, 
including four CpGs located within the gene 
CASZ1. These four sites in CASZ1 were co- 
methylated, absolute r ≥ 0.92 (Figure 4)
Figure 2. Manhattan plots for the set 1 epigenome-wide association study of birth weight (a); the set 2 sample EWAS (b); and the 
meta-analysis EWAS (c). The black and red lines represent the suggestive, and genome-wide significant p-value thresholds of 
P = 1x10−5 and 3.6x10−8, respectively.
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Subsample analysis excluding preterm births
To address the view that preterm births may 
represent a distinct group, we ran the EWASs on 
a subgroup (nSet1 = 1,346, nSet2 = 351) excluding 
those with less than 37 complete weeks gestational 
age at birth (see Supplementary Table 4 for popu-
lation characteristics). In the meta-analysis EWAS 
performed in this subgroup, cg00966482 remained 
significant, with a slightly greater effect 
(β = 0.0213; SE = 0.0037; p = 5.68x10−9). There 
were 36 CpG sites with p < 1x10−5, 23 of which 
appeared in the list of 36 lead sites in the main 
meta-analysis EWAS (Supplementary Table 5).
Adjusting the EWAS model for lifestyle factors
As a sensitivity analysis, we re-ran the EWAS pipe-
line, with corrections for BMI, education, and SIMD 
separately, and all three covariates together. This 
fully-adjusted model resulted in some changes to 
the effect sizes for the 36 sites with p < 1x10−5 in 
the basic meta-analysis output (mean attenuation of 
2.2%, range 12.2% attenuation to 15.3% increase in 
effect size; Supplementary Table 6). There was, how-
ever, good concordance between the effect sizes for 
the top 36 CpG sites identified in the main model, 
and the same sites in this fully-adjusted sensitivity 
model (r = 0.998; Figure 5). Full summary statistics 
for the sensitivity analyses are available at https://doi. 
org/10.7488/ds/2876.
Relationship of birth weight to epigenetic 
signatures of age and telomere length
The mean values for the five epigenetic clocks were: 
Horvath age 44.7 yrs (SD = 10.6); Hannum age 
36.1 yrs (SD = 10.2); PhenoAge 32.8 yrs (SD = 12); 
GrimAge 45.7 yrs (SD = 14.1); DNAm telomere length 
7.6 kilobase pairs (SD = 0.29). Linear regression mod-
els of birth weight residuals (outcome) against five 
signatures of epigenetic age acceleration (the scaled 
residuals from regression of the clock predictors on 
chronological age) revealed significant associations 
between higher birth weight and lower Grim Age 
acceleration (β = −0.083; SE = 0.026, p(FDR) 
Figure 3. Effect sizes for 18 of the top 19 CpG sites in the set 1 sample plotted against the effect sizes in the set 2 sample 
(cg04988918 did not pass quality control in the set 2 array). The point size is determined by the -log10 of the p-values for these hits 
in the set 2 analysis. The two points labelled in black are the two CpG sites which achieved nominal significance in the set 2 study, 
and the three highlighted in red are the three co-methylated CpG sites within the CASZ1 gene.
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= 3.6x10−3) and longer DNAm telomere length 
(β = 0.098; SE = 0.027, p(FDR) = 1.7x10−3; Table 2). 
Associations between birth weight and the other three 
measures of epigenetic age acceleration were non- 
significant (Table 2).
Discussion
We identified one epigenome-wide significant 
association between birth weight and blood-based 
DNA methylation in adulthood, and significant 
associations between birth weight and two epige-
netic age measures.
In the EWAS meta-analysis we observed 
a genome-wide significant association between 
higher birthweight and higher methylation levels at 
cg00966482 (mapping to HERV-FRD and 
LOC221710/SMIM13). HERV-FRD encodes synci-
tin-2, a protein involved in placental embedding, 
whereas LOC221710/SMIM13 is a gene with 
unknown functions [48]. This site was not identified 
in a previous EWAS meta-analysis of birthweight in 
newborns [18]. Of the 36 CpG sites with P < 1x10−5 
in the meta-analysed EWAS, 20 were located within 
known genes. Eighteen of the 20 sites were within 
regions with evidence for transcription factor bind-
ing, open chromatin, or DNase hypersensitivity. 
These may be attractive candidates for further inves-
tigation of the relationship between birth weight, 
DNA methylation, and transcriptional activity 
(Supplementary Table 3). Several of these genes con-
tain SNPs that have genome-wide significant asso-
ciations (GWAS P < 5x10−8) with cardiovascular, 
psychiatric, and developmental pathways 
(Supplementary Table 7). Four of the 36 CpG sites 
exceeding p < 1x10−5 identified in the meta-analysis 
EWAS were highly correlated (min r = 0.92, Figure 
4). Higher birthweight was associated with higher 
methylation levels at these sites, which were located 
within CASZ1, a gene encoding the zinc finger pro-
tein castor homolog 1, a transcriptional activator 
involved in vascular morphogenesis [49]. 
A differentially methylated region in the CASZ1 
gene was recently identified in placental tissue 
between infants born small vs. large for gestational 
age [17]. Additionally, a recent epigenome-wide 
meta-analysis of gestational age in children and 
infants reports several significant sites within 
CASZ1 [50]. In these studies CASZ1 methylation 
was positively associated with both size and 
Figure 4. Correlation plot between methylation at the top 36 CpG sites from the meta-analysis EWAS. The shade and scale of the 
dots represent the magnitude and direction of the correlation between pairs of CpGs.
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gestational age. The findings presented here, 
although non-significant (p ≥ 4.37x10−7), suggest 
that future studies might wish to focus on studying 
this relationship between birth weight and CASZ1 
methylation in further detail. Genetic variants in 
CASZ1 have previously been implicated by GWAS 
in various aspects of cardiovascular health 
(Supplementary Table 7). These have included stu-
dies in multi-ethnic populations on blood pressure 
[51,52], and on other cardiovascular health issues 
such as atrial fibrillation [53] and stroke [54].
Sensitivity analyses that excluded preterm births or 
adjusted individually and collectively for a series of 
possible confounder/mediator lifestyle variables 
resulted in only minor changes to the effect sizes of 
the primary model. However, the covariate adjust-
ments did result in increased p-values for all CpG 
sites, suggesting that replication in larger samples 
and further work to investigate the possibility of med-
iation by lifestyle factors should be considered. The 
analysis excluding preterm births identified the same 
epigenome-wide significant site (cg00966482, HERV- 
FRD/SMIM13 locus) as the primary analysis. 
However, there was an increase in the effect size, 
resulting in a lower p-value for this CpG 
(p = 5.68x10−9). There were some differences between 
the CpGs identified at a suggestive epigenome-wide 
threshold of p < 1x10−5 (36 in both analyses). This may 
indicate differences in the biological pathways asso-
ciated with birth weight in adults, according to the 
length of gestation, and would be an interesting topic 
for further study.
Figure 5. Effect sizes for the main meta-analysis EWAS, and the fully-adjusted sensitivity analysis model. The hollow point labelled in 
black is cg00966482, in the HERV-FRD/SMIM13 gene which achieved epigenome-wide significance in the main model meta-analysis. 
The points in red are in the four CpG sites in the gene CASZ1 which had p < 1x10−5 in the meta-analysis EWAS.
Table 2. Outputs of linear regression models between birth weight 
residuals and five epigenetic signatures of accelerated biological 
ageing – Horvath (Intrinsic Epigenetic Age Acceleration; IEAA), 
Hannum, PhenoAge, GrimAge, and DNAmTL.
Clock Standardised Beta SE P P.adj
Horvath 3.2x10−3 0.025 0.90 0.90
Hannum −6.2x10−3 0.027 0.82 0.90
GrimAge −0.083 0.026 1.4x10−3 3.6x10−3
PhenoAge −0.042 0.027 0.12 0.20
DNAmTL 0.098 0.027 3.3x10−4 1.7x10−3
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Significant associations are demonstrated 
between birth weight and epigenetic predictors of 
ageing, mortality, and cellular senescence. Higher 
birth weight is associated with lower GrimAge 
acceleration [26] and longer telomeres as esti-
mated by DNAm data [27]. The effect sizes are 
relatively small; for instance, with astandardised 
Beta value of −0.083 between GrimAge accelera-
tion and birth weight. These results, however 
modest, are supportive of the known associations 
between low birth weight and a broad range of 
adverse health outcomes. We did not find signifi-
cant associations between birth weight and 
Horvath Age [23], Hannum Age [24], or 
PhenoAge [25] here. We have previously found 
that GrimAge outperforms the other clocks in 
the prediction of self-reported disease burden 
and clinical traits in GS [22], and the creators of 
GrimAge reported its superiority in predicting 
onset of a host of health conditions [26]. The 
DNAm estimate of telomere length performs 
a different function than the other epigenetic age 
estimators, as it specifically predicts telomere 
length – a measure of cellular age. The DNAmTL 
result suggests a relationship between lower birth 
weight and accelerated ageing at a cellular level, 
while the GrimAge result demonstrates this at 
a whole-body level. It is of interest that an associa-
tion exists between birth weight and some, but not 
all, of the epigenetic age predictors tested. It is 
possible that some of the specific variables 
included in the different clocks might underlie 
this observation. For instance, GrimAge contains 
a methylation-based proxy for leptin [26], 
a hormone involved in regulating food intake 
and energy expenditure, which is likely to be 
linked to adult weight. In turn, adult weight 
associates with birth weight [43]. In contrast, 
PhenoAge is calculated based on methylation 
proxies primarily of inflammatory processes, 
which may not associate with birth weight as 
strongly; meanwhile the Hannum and Horvath 
clocks are more broadly trained on age, and so 
may not be picking up the same level of detail on 
susceptibility to ill-health. Maternal GrimAge 
acceleration during pregnancy has recently been 
associated with shorter gestation and, indepen-
dently, lower birthweight of the offspring in 
a small sample of pregnant women [55]. This 
indicates the potential utility of GrimAge in 
describing both processes relevant to foetal devel-
opment, and the later-life consequences of the 
foetal experience.
Strengths and limitations
This study exploited rarely available data linkage 
capacity to acquire neonatal information from 
birth medical records. This was then linked to 
DNAm in a large adult sample. There are, how-
ever, some limitations inherent to the design of 
this study. Longitudinal data would allow analysis 
of the persistence of DNAm signatures across 
time, although this has been investigated in pre-
vious studies [18]. A further limitation to this 
study is the lack of maternal characteristics avail-
able for inclusion in our models. As GS is a cross- 
sectional study, and birth information was derived 
from multiple historical sources, this information 
was not consistently available for our sample.
DNAm data were derived from whole blood 
taken during adulthood, so our findings might 
not generalize to other tissue types. However, 
there are advantages to interrogating blood-based 
methylation levels: first, it is the only tissue type 
that is readily available in large epidemiological 
cohorts; and second, it is systemic and tracks mul-
tiple biological processes including biomarkers of 
inflammation, cardiovascular disease, cardiometa-
bolic disease, all of which are relevant processes 
related to birthweight.
Conclusions
This study presents the first epigenome wide asso-
ciation study of birth weight on DNA methylation 
in adulthood, alongside associations between birth 
weight and both epigenetic age acceleration and 
telomere length. The Developmental Origins of 
Health and Disease theory predicts that birth 
weight, which may be seen as a marker of the 
intrauterine environment, is associated with out-
comes in many domains of adult health, and it has 
been proposed that these associations may be 
reflected in the epigenome. We found evidence to 
support this at both the level of single CpG site 
methylation, and at the level of broader mortality 
and health-related DNAm phenotypes.
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